ASH Share Price | Ashland, Inc. Stock Analysis & Recommendation

Q: What does Ashland, Inc. do?

Overview:Ashland, Inc. is a global specialty chemicals company operating in the FMCG industry, categorized as a small-cap firm.Financial Snapshot:- Most recent Net Sales: 479 Million (Quarterly Results - Mar 2025)- Most recent Net Profit: 30 Million (Quarterly Results - Mar 2025)- Market-cap: USD 2,243.60 Million (Small Cap)Key Metrics:- P/E: NA (Loss Making)- Industry P/E: NA- Dividend Yield: 186.72%- Debt Equity: 0.45- Return on Equity: -2.42%- Price to Book: 0.88Contact Details:- Address: 8145 BLAZER DRIVE, WILMINGTON DE: 19808- Tel: 1 304 9953000- Fax: 1 302 6555049- Website: https://www.ashland.com/

Q: Who are in the management team of Ashland, Inc.?

As of March 2022, the management team of Ashland, Inc. includes Mr. Guillermo Novo, who serves as the Chairman of the Board and Chief Executive Officer. Additionally, Dr. Jay Ihlenfeld holds the position of Lead Independent Director. The board also comprises several Independent Directors: Mr. Brendan Cummins, Mr. William Dempsey, Ms. Susan Main, and Mr. Jerome Peribere.

Q: Is Ashland, Inc. overvalued or undervalued?

As of 30 April 2025, the valuation grade for Ashland, Inc. has moved from expensive to risky, indicating a shift in perception regarding its financial health and market position. Based on the available metrics, the company appears to be overvalued. Key ratios include a Price to Book Value of 0.90, an EV to EBITDA of 8.30, and a Dividend Yield of 182.88%, which, despite being high, may not sufficiently compensate for the company's negative return on equity of -2.42%.In comparison to peers, Ashland's valuation metrics are concerning; for instance, The J. M. Smucker Co. has a P/E ratio of 23.79 and an EV to EBITDA of 12.12, while Conagra Brands, Inc. shows a more attractive EV to EBITDA of 9.96. These comparisons suggest that Ashland is not only lagging behind its peers but also carries a higher risk profile. Although recent stock performance data is not available, the overall valuation story indicates that investors should approach Ashland with caution given its current standing in the market.

Q: Is Ashland, Inc. technically bullish or bearish?

As of 3 October 2025, the technical trend for Ashland, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, with key indicators supporting this view including a bearish MACD on both weekly and monthly time frames, and a bearish daily moving average. The Bollinger Bands also indicate a mildly bearish trend on both weekly and monthly levels. Although the monthly RSI shows bullish momentum, it is countered by a bearish KST on the monthly timeframe. In terms of performance, Ashland has underperformed significantly compared to the S&P 500, with a year-to-date return of -31.43% versus the S&P 500's 14.18%, and a one-year return of -42.75% compared to the S&P 500's 17.82%.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

605.99 k

Shareholding (Dec 2025)

FII

11.18%

Held by 132 FIIs

DII

28.74%

Held by 66 DIIs

Promoter

0.00%

How big is Ashland, Inc.?

22-Jun-2025

As of Jun 18, Ashland, Inc. has a market capitalization of 2,243.60 million and net sales of 1,950.00 million, with a net profit of -86.00 million for the latest four quarters. As of Sep 24, shareholder's funds are 2,868.00 million and total assets are 5,645.00 million.

View full answer

What does Ashland, Inc. do?

22-Jun-2025

Ashland, Inc. is a global specialty chemicals company in the FMCG sector, with a market cap of approximately $2.24 billion. As of March 2025, it reported net sales of $479 million and a net profit of $30 million.

View full answer

Who are in the management team of Ashland, Inc.?

22-Jun-2025

As of March 2022, Ashland, Inc.'s management team includes Mr. Guillermo Novo as Chairman and CEO, with Dr. Jay Ihlenfeld as Lead Independent Director, alongside Independent Directors Mr. Brendan Cummins, Mr. William Dempsey, Ms. Susan Main, and Mr. Jerome Peribere.

View full answer

Is Ashland, Inc. overvalued or undervalued?

20-Sep-2025

As of April 30, 2025, Ashland, Inc. is considered risky and overvalued compared to peers, with concerning financial metrics including a Price to Book Value of 0.90, an EV to EBITDA of 8.30, and a negative return on equity of -2.42%, suggesting investors should exercise caution.

View full answer

Is Ashland, Inc. technically bullish or bearish?

07-Oct-2025

As of October 3, 2025, Ashland, Inc. is in a mildly bearish trend, indicated by bearish MACD and moving averages, while underperforming the S&P 500 with a year-to-date return of -31.43%.

View full answer

Compare Ashland, Inc. with Similar Stocks

Hostess Brands, Inc.Lancaster Colony Corp.Flowers Foods, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Healthy long term growth as Operating profit has grown by an annual rate -18.37%

Flat results in Jun 25

Risky - Negative Operating Profits

Consistent Underperformance against the benchmark over the last 3 years

Mojo Parameters

Stock DNA

Industry

FMCG

Market cap

USD 2,965 Million (Small Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

2.63%

Debt Equity

0.56

Return on Equity

1.33%

Price to Book

1.58

Revenue and Profits:

Net Sales:

386 Million

(Quarterly Results - Dec 2025)

Net Profit:

-14 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-4.74%

6 Months

2.91%

1 Year

-6.0%

2 Years

-42.55%

3 Years

-45.04%

4 Years

-37.8%

5 Years

-36.38%

Ashland, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-5.09%

EBIT Growth (5y)

-20.42%

EBIT to Interest (avg)

3.11

Debt to EBITDA (avg)

1.93

Net Debt to Equity (avg)

0.45

Sales to Capital Employed (avg)

0.51

Tax Ratio

60.00%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

4.98%

ROE (avg)

5.12%

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.21

EV to EBIT

41.07

EV to EBITDA

9.07

EV to Capital Employed

1.13

EV to Sales

1.82

PEG Ratio

Dividend Yield

93.49%

ROCE (Latest)

2.75%

ROE (Latest)

-6.57%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

Bullish

No Signal

Bollinger Bands

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Mildly Bullish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 91 Schemes (60.05%)

Foreign Institutions

Held by 132 Foreign Institutions (11.18%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -19.25% vs 3.24% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -142.42% vs 104.59% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "386.00",
          "val2": "478.00",
          "chgp": "-19.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "52.00",
          "val2": "112.00",
          "chgp": "-53.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "17.00",
          "val2": "16.00",
          "chgp": "6.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-3.00",
          "val2": "-6.00",
          "chgp": "50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-14.00",
          "val2": "33.00",
          "chgp": "-142.42%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-15.50%",
          "val2": "127.60%",
          "chgp": "-14.31%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Sep 2025 is -13.68% vs -3.56% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Sep 2025 is -513.07% vs 18.45% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,824.00",
          "val2": "2,113.00",
          "chgp": "-13.68%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "386.00",
          "val2": "444.00",
          "chgp": "-13.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "63.00",
          "val2": "55.00",
          "chgp": "14.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-716.00",
          "val2": "-32.00",
          "chgp": "-2,137.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-822.00",
          "val2": "199.00",
          "chgp": "-513.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "53.70%",
          "val2": "54.40%",
          "chgp": "-0.07%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

386.00

478.00

-19.25%

Operating Profit (PBDIT) excl Other Income

52.00

112.00

-53.57%

Interest

17.00

16.00

6.25%

Exceptional Items

-3.00

-6.00

50.00%

Consolidate Net Profit

-14.00

33.00

-142.42%

Operating Profit Margin (Excl OI)

-15.50%

127.60%

-14.31%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is -19.25% vs 3.24% in Sep 2025

Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is -142.42% vs 104.59% in Sep 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Sep'25

Sep'25

Sep'24

Change(%)

Net Sales

1,824.00

2,113.00

-13.68%

Operating Profit (PBDIT) excl Other Income

386.00

444.00

-13.06%

Interest

63.00

55.00

14.55%

Exceptional Items

-716.00

-32.00

-2,137.50%

Consolidate Net Profit

-822.00

199.00

-513.07%

Operating Profit Margin (Excl OI)

53.70%

54.40%

-0.07%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Sep 2025 is -13.68% vs -3.56% in Sep 2024

Consolidated Net Profit

YoY Growth in year ended Sep 2025 is -513.07% vs 18.45% in Sep 2024

All Annual Results

Company CV

About Ashland, Inc.

Ashland, Inc.

FMCG

Ashland Global Holdings Inc. is a global specialty chemicals company. The Company operates through two segments: Specialty Ingredients, and Intermediates and Solvents. The Specialty Ingredients provides cellulose ethers, vinyl pyrrolidones and biofunctionals for consumer and industrial applications, including personal care, pharmaceutical, health and wellness, food and beverage, coatings and energy. In addition, it offers chemical technologies in gelcoats, coatings, and intermediates and solvents. The Intermediates and Solvents division is a producer of 1,4 butanediol and its derivatives, including tetrahydrofuran and n-methylpyrrolidone. The Company serves customers in a wide range of consumer and industrial markets, including adhesives, architectural coatings, automotive, construction, energy, food and beverage and personal care.

Company Coordinates

Company Details

8145 BLAZER DRIVE , WILMINGTON DE : 19808

Tel: 1 304 9953000

https://www.ashland.com/

Registrar Details